Literature DB >> 12504677

Protein tyrosine kinases: autoregulation and small-molecule inhibition.

Stevan R Hubbard1.   

Abstract

Receptor and non-receptor protein tyrosine kinases (PTKs) are essential enzymes in cellular signaling processes that regulate cell growth, differentiation, migration and metabolism. The kinase activity of PTKs is tightly controlled through steric, autoregulatory mechanisms, as well as by the action of protein tyrosine phosphatases. Recent structural studies have revealed several modes of autoregulation governing the catalytic state of these enzymes. Aberrant catalytic activity of many PTKs, via mutation or overexpression, plays an important role in numerous pathological conditions, including cancer. Structural studies of the Abl tyrosine kinase domain in complex with the small-molecule inhibitor STI571 provide a molecular basis for understanding the specificity determinants of this highly successful drug used in the treatment of chronic myeloid leukemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12504677     DOI: 10.1016/s0959-440x(02)00383-4

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  15 in total

1.  Gastric mucosal proliferative and total tyrosine kinases activities increase in Helicobacter pylori-induced chronic gastritis.

Authors:  Justyna Kotynia; Radzislaw Kordek; Alicja Kozlowska; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2005

2.  Crystal structure-based selective targeting of the pyridoxal 5'-phosphate dependent enzyme kynurenine aminotransferase II for cognitive enhancement.

Authors:  Franca Rossi; Casazza Valentina; Silvia Garavaglia; Korrapati V Sathyasaikumar; Robert Schwarcz; Shin-Ichi Kojima; Keisuke Okuwaki; Shin-Ichiro Ono; Yasushi Kajii; Menico Rizzi
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

3.  N⁴-Aryl-6-substitutedphenylmethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as receptor tyrosine kinase inhibitors.

Authors:  Aleem Gangjee; Sonali Kurup; Michael A Ihnat; Jessica E Thorpe; Bryan Disch
Journal:  Bioorg Med Chem       Date:  2011-12-08       Impact factor: 3.641

4.  Tyrosine kinase inhibitors: Multi-targeted or single-targeted?

Authors:  Fleur Broekman; Elisa Giovannetti; Godefridus J Peters
Journal:  World J Clin Oncol       Date:  2011-02-10

5.  Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, Src-related Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal Myristoylation Sites (SRMS).

Authors:  Raghuveera Kumar Goel; Marta Paczkowska; Jüri Reimand; Scott Napper; Kiven Erique Lukong
Journal:  Mol Cell Proteomics       Date:  2018-03-01       Impact factor: 5.911

6.  DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitro.

Authors:  Xiao-Bin Guo; Xian-Jie Chen; Lin-Jiang Tong; Xia Peng; Min Huang; Hong-Chun Liu; Hong Liu; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2015-06-01       Impact factor: 6.150

7.  Autoregulation of Parkin activity through its ubiquitin-like domain.

Authors:  Viduth K Chaugule; Lynn Burchell; Kathryn R Barber; Ateesh Sidhu; Simon J Leslie; Gary S Shaw; Helen Walden
Journal:  EMBO J       Date:  2011-06-21       Impact factor: 11.598

8.  Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy.

Authors:  J Rafael Sierra; Virna Cepero; Silvia Giordano
Journal:  Mol Cancer       Date:  2010-04-12       Impact factor: 27.401

9.  Mass spectrometry based method to increase throughput for kinome analyses using ATP probes.

Authors:  F E McAllister; M Niepel; W Haas; E Huttlin; P K Sorger; S P Gygi
Journal:  Anal Chem       Date:  2013-04-22       Impact factor: 6.986

Review 10.  The alpha-kinase family: an exceptional branch on the protein kinase tree.

Authors:  Jeroen Middelbeek; Kristopher Clark; Hanka Venselaar; Martijn A Huynen; Frank N van Leeuwen
Journal:  Cell Mol Life Sci       Date:  2009-12-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.